Valerie Eldridge v. HHS - Influenza, Shoulder Injury Related to Vaccine Administration (SIRVA) (2020)
Case summary [AI summaries can sometimes make mistakes]
Valerie Eldridge filed a petition for compensation under the National Vaccine Injury Compensation Program on January 31, 2019, alleging she suffered a shoulder injury related to vaccine administration (SIRVA) after receiving an influenza vaccine in her right shoulder on October 7, 2017. She further alleged that she experienced the residual effects of her SIRVA for more than six months.
The respondent denied that the petitioner sustained a Table SIRVA within the Table timeframe and denied that the flu vaccine caused her alleged shoulder injury and residual effects. The parties filed a joint stipulation on May 19, 2020, agreeing to settle the case.
Pursuant to the stipulation, Chief Special Master Brian H. Corcoran awarded Valerie Eldridge $75,000.00 in compensation for all items of damages.
The decision was entered on June 24, 2020. Petitioner was represented by Kristina E.
Grigorian and Jeffrey S. Pop of Jeffrey S.
Pop & Associates. Respondent was represented by Voris Edward Johnson of the U.S.
Department of Justice.
Theory of causation
Petitioner Valerie Eldridge alleged a Shoulder Injury Related to Vaccine Administration (SIRVA) following an influenza vaccine administered on October 7, 2017, and that the residual effects lasted more than six months. Respondent denied that the injury was a Table SIRVA within the Table timeframe and denied that the vaccine caused the injury. The parties reached a joint stipulation for settlement. Chief Special Master Brian H. Corcoran adopted the stipulation as his decision. The award was a lump sum of $75,000.00, representing compensation for all items of damages. The decision was entered on June 24, 2020. Petitioner was represented by Kristina E. Grigorian and Jeffrey S. Pop. Respondent was represented by Voris Edward Johnson. The public decision does not describe the specific mechanism of injury, expert testimony, or detailed clinical facts beyond the allegation of SIRVA.
Source PDFs
USCOURTS-cofc-1_19-vv-00181